Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback